Blood Bags Market Size, Share & Trends Analysis Report By Product (Single Blood Bag, Double Blood Bag, Triple Blood Bag), By Application (Collection Bag, Transfer Bag), By End Use (Hospitals & Clinics, Blood Banks), By Region, And Segment Forecasts, 2025 - 2030

Blood Bags Market Size & Trends

The global blood bags market size was estimated at USD 342.31 million in 2024 and is projected to grow at a CAGR of 7.50% from 2025 to 2030. Growing awareness and participation in voluntary blood donation drives are increasing the availability of collected blood, boosting demand for safe and efficient blood storage solutions. This is encouraging hospitals and blood banks to invest more in high-quality blood bags. Healthcare providers are increasingly prioritizing digital traceability in compliance with international standards, and this trend is expected to become a foundational feature in modern transfusion medicine as global supply chains evolve toward data-centric operations.

A significant trend shaping the industry is the integration of RFID-enabled traceability and smart labelling technologies into blood collection and transfusion systems. Advanced digital tracking solutions are being embedded into blood bags to ensure end-to-end visibility of blood units, from donor to recipient. This is not only enhancing the accuracy of inventory management across blood banks and hospitals but also improving patient safety by minimizing transfusion-related errors.

Drivers, Opportunities & Restraints

One of the strongest growth drivers for the industry is the rising demand for blood and blood components due to increasing surgical procedures and trauma cases worldwide. Cardiovascular surgeries, cancer treatments, and organ transplants are on the rise, each requiring significant volumes of blood products. Simultaneously, the prevalence of chronic conditions such as anemia and hemophilia is expanding the use of blood components like red cells and plasma.

Governments and private health institutions are intensifying efforts to improve blood collection and storage infrastructure, which is directly accelerating the procurement of blood bags. This demand is further reinforced by aging populations and the consistent need for safe transfusion support in emergency care settings.

The growing momentum toward self-sufficiency in blood collection and storage in developing economies presents a compelling opportunity for stakeholders in the blood bags market. Countries in Asia Pacific, Africa, and parts of Latin America are ramping up investments in national blood programs and public health infrastructure, driven by both governmental initiatives and international health partnerships.

There is a notable shift from reliance on imports to establishing domestic manufacturing capabilities for transfusion equipment, including blood bags. Market entrants offering cost-effective, high-quality, and WHO-compliant products stand to benefit significantly from these emerging healthcare frameworks that are prioritizing safety, efficiency, and sustainability in blood management systems.

Despite promising growth prospects, the market faces a notable restraint in the form of stringent regulatory requirements and prolonged product approval timelines. Blood bags fall under the classification of medical devices and are subject to extensive scrutiny by regulatory bodies such as the FDA, EMA, and other national health authorities. Manufacturers must adhere to rigorous safety, sterility, and biocompatibility standards, which can delay market entry and elevate development costs.

Product Insights

Single blood bags dominated the industry, accounting for a market share of 39.88% in 2024. The demand for single blood bags is largely propelled by their widespread usage in primary healthcare settings and during routine blood donation camps, particularly in emerging markets. These bags offer a cost-effective solution for whole blood collection where advanced separation of components is not required. With government-sponsored rural health outreach programs gaining momentum in countries such as India, Indonesia, and Nigeria, the consumption of single blood bags has seen a considerable uptick as they meet the immediate need for basic transfusion procedures.

Triple blood bags are emerging as a strategic raw material for the production of high-value bio-based chemicals and engineered polymers and are anticipated to grow at the fastest CAGR of 8.36% over the forecast period. The segment is witnessing strong growth driven by the increasing practice of component therapy, where whole blood is separated into red cells, plasma, and platelets. This method allows for optimal utilization of a single donation and is gaining adoption in tertiary care hospitals and advanced clinical setups. In countries with rising incidences of oncology and cardiovascular diseases, triple bags support high-demand therapeutic applications, creating long-term procurement cycles among healthcare providers focused on maximizing blood unit efficiency.

Application Insights

Collection blood bags dominated the market, accounting for a revenue share of 61.23% in 2024. An essential driver for the collection blood bags segment is the rapid expansion of mobile blood donation units and community-based donor engagement programs. Public health authorities and non-profit organizations are increasingly relying on portable, hygienic, and easy-to-use blood collection solutions to improve donor turnout in remote areas. As these campaigns emphasize donor safety and ease of use, the demand for sterile, high-capacity blood collection bags with integrated needle safety features continues to grow.

The transfer blood bags segment is expected to grow at a substantial CAGR of 7.16% from 2025 to 2030. The rising need for intra-facility and inter-facility transfer of blood components is advancing the demand for transfer blood bags. With large hospital networks and regional healthcare centers managing complex patient logistics, there is a heightened requirement for bags that can handle secure and contamination-free movement of blood products. Furthermore, regulatory mandates for traceability and quality control during transit are pushing healthcare institutions to adopt specialized transfer bags equipped with tamper-evident seals and durable materials.

End Use Insights

Hospitals & clinics dominated the industry, accounting for a revenue share of 48.61% in 2024. In hospitals and clinics, the growing incidence of high-risk surgeries and specialized treatments such as chemotherapy and organ transplants is a core driver of blood bag demand. These facilities require a constant and diverse inventory of blood products to respond to time-sensitive cases. As clinical protocols become more stringent around blood safety and availability, hospitals are investing in technologically advanced blood bags that support efficient storage and immediate transfusion readiness.

The blood banks segment is projected to witness a substantial CAGR of 4.35% over the forecast period. Blood banks are increasingly turning into centralized hubs for regional blood collection, processing, and distribution, driving significant procurement of multi-chambered blood bags. The shift toward automation and integrated blood management systems has created demand for bags compatible with centrifugation and component separation. With rising accreditation standards and digital inventory monitoring, blood banks are now prioritizing precision and regulatory compliance, stimulating the adoption of high-specification bag systems tailored for long-term preservation and traceability.

Regional Insights

North America blood bags market dominated the global industry and accounted for the largest revenue share of 30.96% in 2024 due to the increasing prevalence of age-related and chronic health conditions, such as cardiovascular diseases and cancers, which necessitate frequent blood transfusions. This medical demand is further amplified by a well-developed healthcare reimbursement structure and the presence of large-scale trauma centers and organ transplant programs. Consequently, hospitals and blood centers across the region are consistently investing in high-capacity, component-separation blood bag systems to meet evolving clinical requirements.

U.S. Blood Bags Market Trends

In the U.S., a unique driver stems from robust federal and private sector collaboration in blood donation awareness campaigns and disaster preparedness initiatives. Organizations like the American Red Cross and AABB have scaled up public education and mobile donation infrastructure, leading to consistent donor engagement. This continuous supply-side activity fuels the demand for sterile, reliable blood bags tailored to both emergency and routine usage across national networks of hospitals and mobile units.

Europe Blood Bags Market Trends

The blood bags market in Europe is significantly driven by stringent regulatory frameworks governing blood safety, such as the EU Blood Directive, which mandates comprehensive quality assurance and traceability standards. These regulations have prompted widespread upgrades in blood collection and storage protocols, particularly among EU member states, pushing hospitals and blood centers to adopt multi-component blood bags with integrated safety features. Additionally, the region’s emphasis on ethical blood sourcing and increased plasma fractionation capacity reinforces long-term demand.

Asia Pacific Blood Bags Market Trends

The blood bags market in Asia Pacific is expected to expand at a rapid CAGR of 8.25% from 2025 to 2030, which can be attributed to large-scale public health initiatives aimed at improving national blood transfusion services and achieving self-sufficiency in blood supply. Countries such as India, China, and the Philippines are expanding their network of blood banks and donation centers under government-backed healthcare reform plans. With a high volume of surgical procedures and childbirth-related transfusions, the region is rapidly scaling up procurement of advanced, cost-efficient blood bag systems that can support both urban and rural health infrastructures.

Key Blood Bags Companies Insights

Key players operating in the blood bags market are undertaking various initiatives to strengthen their presence and increase the reach of their products and services. Strategies such as expansion activities and partnerships are key in propelling the market growth.

Recent Developments

• In February 2025, the health department of Indonesia announced that the country had begun local production of blood bags and hemodialysis machines to strengthen the national health system and reduce reliance on imports.

• In March 2023, Indian scientists at the Institute for Stem Cell Biology and Regenerative Medicine (inStem) developed a novel blood bag using special polymers that capture harmful molecules called damage-associated molecular patterns (DAMPs), increasing blood’s shelf life to 51 days while maintaining transfusion quality. 

Blood Bags Market Report Scope

Global Blood Bags Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global blood bags market report based on product, application, end use, and region:

• Product Outlook (Revenue, USD Million, 2018 - 2030)

  • Single Blood Bag

  • Double Blood Bag

  • Triple Blood Bag

  • Others

• Application Outlook (Revenue, USD Million, 2018 - 2030)

  • Collection Blood Bags

  • Transfer Blood Bags

• End Use Outlook (Revenue, USD Million, 2018 - 2030)

  • Hospitals & Clinics

  • Blood Banks

  • Others

• Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • Germany

    • UK

    • France

    • Italy

    • Spain

  • Asia Pacific

    • China

    • India

    • Japan

    • South Korea

    • Australia

  • Central & South America

    • Brazil

    • Argentina

  • Middle East & Africa

    • Saudi Arabia

    • South Africa

    • UAE